000 01357 a2200421 4500
005 20250514043205.0
264 0 _c20040106
008 200401s 0 0 eng d
022 _a0390-6078
040 _aNLM
_beng
_cNLM
100 1 _aVoso, Maria Teresa
245 0 0 _aRituximab reduces the number of peripheral blood B-cells in vitro mainly by effector cell-mediated mechanisms.
_h[electronic resource]
260 _bHaematologica
_cSep 2002
300 _a918-25 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntibodies, Monoclonal
_xpharmacology
650 0 4 _aAntibodies, Monoclonal, Murine-Derived
650 0 4 _aB-Lymphocytes
_xcytology
650 0 4 _aCD3 Complex
_xmetabolism
650 0 4 _aCD56 Antigen
_xmetabolism
650 0 4 _aCell Count
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aCell Line, Tumor
650 0 4 _aCells, Cultured
650 0 4 _aHumans
650 0 4 _aLeukemia, B-Cell
_xpathology
650 0 4 _aLipopolysaccharide Receptors
_xmetabolism
650 0 4 _aRituximab
700 1 _aPantel, Gitta
700 1 _aRutella, Sergio
700 1 _aWeis, Mirjam
700 1 _aD'Alò, Francesco
700 1 _aUrbano, Raffaella
700 1 _aLeone, Giuseppe
700 1 _aHaas, Rainer
700 1 _aHohaus, Stefan
773 0 _tHaematologica
_gvol. 87
_gno. 9
_gp. 918-25
999 _c12098317
_d12098317